Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth

Journal of Molecular Endocrinology

Volumn 42, Issue 4, 2009, Pages 341-356

  Rezgui, Dellel ^a   Williams, Christopher ^b   Savage, Sharon A ^c   Prince, Stuart N ^a   Zaccheo, Oliver J ^a   Jones, E Yvonne ^d   Crump, Matthew P ^b   Hassan, A Bassim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FIBRONECTIN BINDING PROTEIN; GLYCINE; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; LIGAND; MANNOSE 6 PHOSPHATE; MANNOSE PHOSPHATE; MANNOSE-6-PHOSPHATE; MESSENGER RNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE STRUCTURE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HALF LIFE TIME; LIGAND BINDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; QUANTITATIVE STUDY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; X RAY CRYSTALLOGRAPHY; ANIMAL; CELL MEMBRANE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; KINETICS; METABOLISM; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SURFACE PLASMON RESONANCE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL MEMBRANE; CELL PROLIFERATION; FLOW CYTOMETRY; HALF-LIFE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KINETICS; LIGANDS; LINKAGE DISEQUILIBRIUM; MANNOSEPHOSPHATES; MODELS, MOLECULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RATS; RECEPTOR, IGF TYPE 2; RNA, MESSENGER; SURFACE PLASMON RESONANCE; TRANSFECTION;

EID: 67449152587     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0154     Document Type: Article

References (50)

1. Barrett JC, Fry B, Maller J & Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 263-265.
2. Brown J, Esnouf RM, Jones MA, Linnell J, Harlos K, Hassan AB & Jones EY 2002 Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur. EMBO Journal 21 1054-1062.
3. Brown J, Delaine C, Zaccheo OJ, Siebold C, Gilbert RJ, van Boxel G, Denley A, Wallace JC, Hassan AB, Forbes BE et al. 2008 Structure and functional analysis of the IGF-II/IGF2R interaction. EMBO Journal 27 265-276.
4. Byrd JC, Devi GR, de Souza AT, Jirtle RL & MacDonald RG 1999 Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations. Journal of Biological Chemistry 274 24408-24416.
5. Byrd JC, Park JH, Schaffer BS, Garmroudi F & MacDonald RG 2000 Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor. Journal of Biological Chemistry 275 18647-18656.
6. Christofori G, Naik P & Hanahan D 1994 A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 414-418.
7. Clairmont KB & Czech MP 1989 Chicken and Xenopus mannose 6-phosphate receptors fail to bind insulin-like growth factor II. Journal of Biological Chemistry 264 16390-16392.
8. Clairmont KB & Czech MP 1991 Extracellular release as the major degradative pathway of the insulin-like growth factor II/mannose 6-phosphate receptor. Journal of Biological Chemistry 266 12131-12134.
9. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer EM, Oxvig C & van Deursen J 2004 Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131 1187-1194.
10. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, Wu Y, He X, Powe NR & Feinberg AP 2003 Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 299 1753-1755.
11. Davis SJ, Ward HA, Puklavec MJ, Willis AC, Williams AF & Barclay AN 1990 High level expression in Chinese hamster ovary cells of soluble forms of CD4 T lymphocyte glycoprotein including glycosylation variants. Journal of Biological Chemistry 265 10410-10418.
12. De Souza AT, Hankins GR, Washington MK, Orton TC & Jirtle RL 1995 M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nature Genetics 11 447-449 issn: 1061-4036.
13. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J & Bax A 1995 NMRPipe: a multidimensional spectral processing system based on UNIX pipes. Journal of Biomolecular NMR 6 277-293.
14. Dennis PA & Rifkin DB 1991 Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. PNAS 88 580-584.
15. Devi GR, De Souza AT, Byrd JC, Jirtle RL & MacDonald RG 1999 Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Cancer Research 59 4314-4319.
16. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D & Hassan AB 2005 Insulin-like growth factor ligands, receptors, and binding proteins in cancer. Journal of Pathology 205 145-153.
17. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM et al. 2007 A second generation human haplotype map of over 3.1 million SNPs. Nature 449 851-861.
18. Garrone S, Radetti G, Sidoti M, Bozzola M, Minuto F & Barreca A 2002 Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children. Journal of Clinical Endocrinology and Metabolism 87 5455-5460.
19. Ghosh P, Dahms NM & Kornfeld S 2003 Mannose 6-phosphate receptors: new twists in the tale. Nature Reviews. Molecular Cell Biology 4 202-212.
20. Hancock MK, Haskins DJ, Sun G & Dahms NM 2002a Identification of residues essential for carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate receptor. Journal of Biological Chemistry 277 11255-11264.
21. Hancock MK, Yammani RD & Dahms NM 2002b Localization of the carbohydrate recognition sites of the insulin-like growth factor II/ mannose 6-phosphate receptor to domains 3 and 9 of the extracytoplasmic region. Journal of Biological Chemistry 277 47205-47212.
22. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, Iglehart JD & Jirtle RL 1996 M6P/IGF2, receptor: a candidate breast tumor suppressor gene. Oncogene 12 2003-2009.
23. Harper J, Burns JL, Foulstone EJ, Pignatelli M, Zaina S & Hassan AB 2006 Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting. Cancer Research 66 1940-1948.
24. Ito Y, Koessler T, Ibrahim AE, Rai S, Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston JE, Uribe-Lewis S et al. 2008 Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Human Molecular Genetics 17 2633-2643.
25. Kaku K, Osada H, Seki K & Sekiya S 2007 Insulin-like growth factor 2 (IGF2) and IGF2 receptor gene variants are associated with fetal growth. Acta Paediatrica 96 363-367.
26. Kalscheuer VM, Mariman EC, Schepens MT, Rehder H & Ropers HH 1993 The insulin-like growth factor type-2 receptor gene is imprinted in the mouse but not in humans. Nature Genetics 5 74-78.
27. Kiess W, Thomas CL, Greenstein LA, Lee L, Sklar MM, Rechler MM, Sahagian GG & Nissley SP 1989 Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor. Journal of Biological Chemistry 264 4710-4714.
28. Kiess W, Thomas CL, Sklar MM & Nissley SP 1990 Beta-galactosidase decreases the binding affinity of the insulin-like-growth-factor-II/ mannose-6-phosphate receptor for insulin-like-growth-factor II. European Journal of Biochemistry 190 71-77.
29. Killian JK, Oka Y, Jang HS, Fu X, Waterland RA, Sohda T, Sakaguchi S & Jirtle RL 2001 Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Human Mutation 18 25-31.
30. Kolonel LN, Altshuler D & Henderson BE 2004 The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nature Reviews. Cancer 4 519-527.
31. Kong FM, Anscher MS, Washington MK, Killian JK & Jirtle RL 2000 RLM6P/IGF2R, is mutated in squamous cell carcinoma of the lung. Oncogene 19 1572-1578.
32. Kreiling JL, Byrd JC & MacDonald RG 2005 Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor. Journal of Biological Chemistry 280 21067-21077.
33. Linnell J, Groeger G & Hassan AB 2001 Real time kinetics of insulin-like growth factor II (IGF-II) interaction with the IGF-II/ mannose 6-phosphate receptor: the effects of domain 13 and pH. Journal of Biological Chemistry 276 23986-23991.
34. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML & Efstratiadis A 1996 Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Developmental Biology 177 517-535 issn: 0012-1606.
35. Nakayama EE, Tanaka Y, Nagai Y, Iwamoto A & Shioda T 2004 A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS 18 729-738.
36. Ong K, Kratzsch J, Kiess W, Costello M, Scott C & Dunger D 2000 Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants, The ALSPAC study team. Avon longitudinal study of pregnancy and childhood. Journal of Clinical Endocrinology and Metabolism 85 4266-4269.
37. Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, Sicotte H, Staats B, Acharya M, Crenshaw A et al. 2006 SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Research 34 D617-D621.
38. Petry CJ, Ong KK, Wingate DL, Brown J, Scott CD, Jones EY, Pembrey ME & Dunger DB 2005 Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Hormone and IGF Research 15 363-368.
39. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN & Chanock SJ 2007 Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiology Biomarkers & Prevention 16 1667-1674.
40. Sharma M, Pampinella F, Nemes C, Benharouga M, So J, Du K, Bache KG, Papsin B, Zerangue N, Stenmark H et al. 2004 Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. Journal of Cell Biology 164 923-933.
41. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J & Laue ED 2005 The CCPN, data model for NMR spectroscopy: development of a software pipeline. Proteins 59 687-696.
42. Wang ZQ, Fung MR, Barlow DP & Wagner EF 1994 Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372 464-467.
43. Williams C, Rezgui D, Prince SN, Zaccheo OJ, Foulstone EJ, Forbes BE, Norton RS, Crosby J, Hassan AB & Crump MP 2007 Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11. Structure 15 1065-1078.
44. Wutz A, Theussl HC, Dausman J, Jaenisch R, Barlow DP & Wagner EF 2001 Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development 128 1881-1887.
45. Wylie AA, Pulford DJ, McVie-Wylie AJ, Waterland RA, Evans HK, Chen YT, Nolan CM, Orton TC & Jirtle RL 2003 Tissue-specific inactivation of murine M6P/IGF2R. American Journal of Pathology 162 321-328.
46. Xu Y, Goodyer CG, Deal C & Polychronakos C 1993 Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochemical and Biophysical Research Communication 197 747-754.
47. Yandell CA, Dunbar AJ, Wheldrake JF & Upton Z 1999 The kangaroo cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II with low affinity. Journal of Biological Chemistry 274 27076-27082.
48. York SJ, Arneson LS, Gregory WT, Dahms NM & Kornfeld S 1999 The rate of internalization of the mannose 6-phosphate/insulin-like growth factor II receptor is enhanced by multivalent ligand binding. Journal of Biological Chemistry 274 1164-1171.
49. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I & Sinclair KD 2001 Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nature Genetics 27 153-154.
50. Zaccheo OJ, Prince SN, Miller DM, Williams C, Kemp CF, Brown J, Jones EY, Catto LE, Crump MP & Hassan AB 2006 Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/ mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues. Journal of Molecular Biology 359 403-421.